| |
|
|
|
Acasti Pharma Inc.  
|
|
0.6304 0.07 (0.12%) |
03-05 16:00 |
|
Open: |
0.585 |
Pre close: |
0.5604 |
Target:
|
1.09 
|
|
High: |
0.6595 |
Low: |
0.48 |
Resistance:
|
0.94
1.22
|
|
Volume: |
27,499,411 |
Market Cap: |
113M |
Support:
|
0.48
0.40
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.66
|
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
0.86 |
Signal(12,26,9): |
0.02 |
|
MA(100): |
0.46  |
Stochastic Oscillator |
%K(14,3):
|
11.36 |
|
MA(250): |
0.50 |
%D(3): |
10.97 |
|
Average Volume(K) |
3-Month: |
5352729
|
52-Week |
High:
|
1.22 |
|
10-Days: |
2300992 |
Low: |
0.17 |
|
RSI |
RSI(14):
|
42.63 |
Change(%): |
65.9 |
|
Financials, Statistics and Valuation |
|
EPS |
0.027 |
Return on Equity (ttm) |
24.7 |
Shares Out. (M) |
179.50 |
|
EPS Est. Current Year |
-0.730 |
Return on Assets (ttm) |
-28.3 |
Shares Float (M) |
179.10 |
|
EPS Est. Next Year |
-0.770 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.64 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.66 |
|
Forward EPS |
-0.714 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1780 |
|
Book Value (p.s.) |
0.170 |
EBITDA (p.s.) |
-0.068 |
P/E |
23.35 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.71 |
|
Profit Margin |
3188.89 |
Operating Cash Flow
(M) |
-15.45 |
P/S |
1397.00 |
|
Operating Margin |
-16851.85 |
Levered Free Cash Flow
(M) |
-12.24 |
P/CF |
-7.32 |
|
|
|
|
|
|
